Cosmos Health Inc.
COSMNasdaq
$0.23
↓ -16.4%Jul 17 close · end-of-day
Price
1Y↓ -47.9%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$11.1M
Enterprise Value
$14.0M
P/E
—
P/S
0.2
P/B
0.6
EV/EBITDA
—
PEG
—
FCF Yield
-84.9%
Dividend Yield
—
Revenue (TTM)
$69.5M
Net Income (TTM)
-$21.1M
Free Cash Flow (TTM)
-$9.4M
Gross Margin
10.4%
Operating Margin
-26.0%
Net Margin
-30.4%
ROE
-106.6%
ROIC
-62.8%
Debt / Equity
0.2
Net Cash
-$2.9M
Return 1Y
-48.7%
Company profile
Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company. It offers proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter (OTC) medications, health care, baby products, medical devices, and other products. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes.
- CEO
- Grigorios Siokas
- Sector
- Wholesale Trade
- Industry
- Wholesale
- Employees
- 100
- Website
- cosmosholdingsinc.com
Management & directors
- Terzis GeorgiosChief Financial Officer
- Siokas GrigoriosChief Executive Officer
- Demetriades Demetrios G.Secretary
Roles derived from SEC Form 4 filings.
Earnings
COSM Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$17.9M↑ +30.7%
Diluted EPS-$0.06↑ +100.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $55.4M | $56.2M | $50.3M | $53.4M | $54.4M | $65.3M |
| Gross profit | $8.1M | $8.3M | $6.0M | $4.3M | $4.3M | $7.9M |
| Operating income | $2.7M | -$4.5M | -$7.5M | -$21.8M | -$15.5M | -$16.7M |
| Net income | $820,786.00 | -$8.0M | -$13.8M | -$18.5M | -$16.2M | -$19.1M |
| Diluted EPS | $0.06 | -$23.74 | -$33.16 | -$2.15 | -$1.17 | -$0.63 |
| Operating cash flow | -$11.5M | -$7.1M | -$14.9M | -$15.6M | -$7.7M | -$8.4M |
| Free cash flow | -$11.6M | -$7.7M | -$14.9M | -$16.9M | -$8.1M | -$8.5M |
| Gross margin | 14.5% | 14.8% | 11.8% | 8.1% | 7.9% | 12.1% |
| Operating margin | 4.9% | -8.1% | -14.8% | -40.9% | -28.6% | -25.6% |
| Net margin | 1.5% | -14.2% | -27.5% | -34.7% | -29.7% | -29.3% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.2M | $12.4M | $14.2M | $13.7M | $14.7M | $17.1M | $19.7M | $17.9M |
| Gross profit | $767,248.00 | $1.2M | $1.0M | $2.0M | $1.2M | $2.6M | $2.1M | $1.4M |
| Operating income | -$2.5M | -$2.2M | -$9.0M | -$833,145.00 | -$2.6M | -$1.8M | -$11.4M | -$2.2M |
| Net income | -$2.6M | -$8.4M | -$3.3M | -$818,097.00 | -$2.8M | -$5.4M | -$10.1M | -$2.8M |
| Diluted EPS | -$0.15 | -$0.45 | -$0.46 | -$0.03 | -$0.10 | -$0.17 | -$0.33 | -$0.06 |
| Operating cash flow | -$1.2M | $739,774.00 | -$3.8M | -$186,316.00 | -$1.2M | -$2.5M | -$4.6M | -$1.1M |
| Free cash flow | -$1.2M | $511,007.00 | -$3.9M | -$198,846.00 | -$1.2M | -$2.5M | -$4.6M | -$1.1M |
| Gross margin | 5.8% | 9.7% | 7.1% | 14.9% | 7.9% | 15.2% | 10.6% | 7.7% |
| Operating margin | -18.9% | -18.0% | -63.0% | -6.1% | -17.9% | -10.6% | -57.9% | -12.2% |
| Net margin | -19.6% | -67.5% | -23.5% | -6.0% | -19.2% | -31.3% | -51.5% | -15.6% |
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-16 | Terzis Georgios· Chief Financial Officer | Buy | 168,135 | $0.25 | $42,000.12 | filing |
| 2026-06-11 | Siokas Grigorios· Chief Executive Officer | Buy | 218,447 | $0.21 | $45,000.08 | filing |
| 2026-06-10 | Siokas Grigorios· Chief Executive Officer | Buy | 701,447 | $0.23 | $160,000.06 | filing |
| 2026-05-19 | Siokas Grigorios· Chief Executive Officer | Award | 2,350,000 | $0.28 | $665,050.00 | filing |
| 2026-05-19 | Terzis Georgios· Chief Financial Officer | Award | 850,000 | $0.28 | $240,550.00 | filing |
| 2026-05-19 | Aslidis Anastasios | Award | 40,000 | $0.28 | $11,320.00 | filing |
| 2026-05-19 | Demetriades Demetrios G.· Secretary | Award | 20,000 | $0.28 | $5,660.00 | filing |
| 2026-05-19 | Bhutawala Suhel | Award | 20,000 | $0.28 | $5,660.00 | filing |
| 2026-05-19 | Hoidas John James | Award | 20,000 | $0.28 | $5,660.00 | filing |
| 2026-05-19 | Karkantzos Theodoros Christos | Award | 20,000 | $0.28 | $5,660.00 | filing |
| 2026-02-12 | Siokas Grigorios· Chief Executive Officer | Buy | 388,532 | $0.37 | $145,000.14 | filing |
| 2026-02-11 | Siokas Grigorios· Chief Executive Officer | Buy | 291,262 | $0.41 | $119,999.94 | filing |
| 2026-01-23 | Siokas Grigorios· Chief Executive Officer | Buy | 90,325 | $0.50 | $44,999.92 | filing |
| 2026-01-20 | Siokas Grigorios· Chief Executive Officer | Buy | 353,321 | $0.50 | $174,999.89 | filing |
| 2026-01-14 | Siokas Grigorios· Chief Executive Officer | Buy | 493,495 | $0.45 | $220,000.07 | filing |
| 2026-01-12 | Siokas Grigorios· Chief Executive Officer | Buy | 113,185 | $0.50 | $56,999.97 | filing |
| 2026-01-08 | Siokas Grigorios· Chief Executive Officer | Buy | 156,190 | $0.52 | $81,000.13 | filing |
| 2026-01-07 | Siokas Grigorios· Chief Executive Officer | Buy | 124,880 | $0.52 | $65,000.04 | filing |
| 2026-01-06 | Siokas Grigorios· Chief Executive Officer | Buy | 133,953 | $0.54 | $71,999.74 | filing |
| 2025-12-19 | Siokas Grigorios· Chief Executive Officer | Buy | 88,314 | $0.49 | $43,000.09 | filing |
| 2025-12-15 | Siokas Grigorios· Chief Executive Officer | Buy | 168,472 | $0.42 | $70,000.12 | filing |
| 2025-11-28 | Siokas Grigorios· Chief Executive Officer | Buy | 76,360 | $0.64 | $49,000.21 | filing |
| 2025-11-25 | Siokas Grigorios· Chief Executive Officer | Buy | 55,732 | $0.63 | $34,999.70 | filing |
| 2025-11-21 | Siokas Grigorios· Chief Executive Officer | Buy | 56,080 | $0.68 | $37,999.81 | filing |
| 2025-11-20 | Siokas Grigorios· Chief Executive Officer | Buy | 51,315 | $0.62 | $32,000.03 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.